Animal Antimicrobial Peptides Market Report 2025 (Global Edition)

Global Animal Antimicrobial Peptides Market Report 2025 Market Size Split by Product (Plant Antimicrobial Peptides, Bacterial Antimicrobial Peptides, Animal Antimicrobial Peptides, Insect Antimicrobia...

Animal Antimicrobial Peptides Market Report Description

We have various report editions of Animal Antimicrobial Peptides Market, hence please contact our sales team and author directly to obtain/purchase a desired Edition eg, Global Edition, Regional Edition, Country Specific Report Edition, Company Profiles, Forecast Edition, etc. Request for your Free Sample PDF/Online Access.

Animal Antimicrobial Peptides Market Insights Video

Competitive Landscape of the Animal Antimicrobial Peptide Market

The competitive landscape of the animal antimicrobial peptide market is characterized by a mix of established pharmaceutical companies and emerging biotech firms. Key players focus on research and development to innovate and enhance peptide efficacy against bacterial infections. Partnerships and collaborations are common to accelerate product development. Regulatory approvals and market access strategies play crucial roles, as do the increasing demands for sustainable and alternative veterinary treatments, driving competition and investment in this growing sector.

In June 2022, bioMérieux, Evotec S.E., and Boehringer Ingelheim formed a joint venture to create the next generation of antimicrobials to fight antimicrobial resistance. Through this strategic cooperation, the significant worldwide challenge of drug-resistant infections is addressed by utilizing the expertise of each organization. (Source: https://www.boehringer-ingelheim.com/science-innovation/human-health-innovation/joint-venture-fight-antimicrobial-resistance) In July 2020, to create transgenic monoclonal antibody platforms for the development of novel veterinary therapeutics, Zoetis (U.S.) purchased Trianni Inc. (U.S.). (Source: https://news.zoetis.com/press-releases/press-release-details/2020/Trianni-and-Zoetis-Announce-Agreement-to-Develop-a-Transgenic-Antibody-Discovery-Platform-for-Use-in-Animal-Health/default.aspx)

Top Companies Market Share in Animal Antimicrobial Peptides Industry: (In no particular order of Rank)

• Novozymes A/S
• PolyPeptide Group
• Bachem Holding AG
• Wuxi AppTec
• AnaSpec Inc. (a Eurofins Company)
• Merial
• Ipsen S.A.
• AstraZeneca
• Pfizer Inc.
• GlaxoSmithKline plc
• Merck & Co. Inc.
• Confidential Data
• Access The Paid Version
• Data Hidden

*List of Second Tier Companies, List of Third Tier/ Start-up Companies (Inquire with sales executive) Request Any Company Profile for Preview Purpose OR Data Validation!

If any Company(ies) of your interest has/have not been disclosed in the above list then please let us know the same so that we will check the data availability in our database and provide you the confirmation or include it in the final deliverables.

Regional Analysis of the Animal Antimicrobial Peptide Market

Which Region Dominates the Animal Antimicrobial Peptide Market in 2024?

According to Cognitive Market Research, North America currently dominates the Animal Antimicrobial Peptides market, and the region is expected to have significant growth during the projected period. This is due to increasing livestock production, rising demand for natural alternatives to antibiotics, and growing awareness of animal health. Additionally, significant investments in research and development of antimicrobial peptides are propelling market growth in the region.

Which Region is Expanding at the Fastest CAGR?

Asia-Pacific is expected to make significant gains during the projected period, with the greatest compound annual growth rate (CAGR). The increasing livestock production, rising awareness of antimicrobial resistance, and the demand for natural alternatives in animal feed and health management solutions.

The current report Scope analyzes Animal Antimicrobial Peptides Market on 5 major region Split (In case you wish to acquire a specific region edition (more granular data) or any country Edition data then please write us on info@cognitivemarketresearch.com

• North America (United States, Canada, Mexico)
• Europe (United Kingdom, France, Germany, Italy, Russia, Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium)
• Asia-Pacific (China, Japan, Korea, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest of APAC)
• South America (Brazil, Argentina, Colombia, Peru, Chile, Rest of South America)
• Middle East and Africa (Saudi Arabia, Turkey, Nigeria, UAE, Egypt, South Africa, GCC Countries, Rest of MEA)

The above graph is for illustrative purposes only.

North America Animal Antimicrobial Peptides

According to Cognitive Market Research, the global Animal Antimicrobial Peptide market size was estimated at USD 226.9 Million, out of which North America held the major market share of more than 40% of the global revenue with a market size of USD 90.76 million in 2024 and will grow at a compound annual growth rate (CAGR) of 10.7% from 2024 to 2031.

• According to Cognitive Market Research, the U.S. had a major share in the Animal Antimicrobial Peptide market with a market size of USD 71.61 million in 2024 and is projected to grow at a CAGR of 10.5% during the forecast period. The U.S. market's Stringent governmental regulations against plastic pollution.
• The Canada Animal Antimicrobial Peptide market had a market share of USD 10.89 million in 2024 and is projected to grow at a CAGR of 11.5% during the forecast period. Canada’s rising awareness among the population.
• The Mexico Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 8.26 million in 2024.

Europe Animal Antimicrobial Peptides

According to Cognitive Market Research, the global Animal Antimicrobial Peptide market size was estimated at USD 226.9 Million, out of which Europe held the market share of more than 30% of the global revenue with a market size of USD 68.07 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.0% from 2024 to 2031.

• The United Kingdom Animal Antimicrobial Peptide market had a market share of USD 11.44 million in 2024 and is projected to grow at a CAGR of 11.8% during the forecast period. In the U.K., Animal Antimicrobial Peptide sales witness an upswing due to the increasing focus on environmental sustainability.
• The France Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 10.2% during the forecast period, with a market size of USD 6.26 million in 2024.
• According to Cognitive Market Research, the German Animal Antimicrobial Peptide market size was valued at USD 13.48 million in 2024 and is projected to grow at a CAGR of 11.2% during the forecast period. In Germany, Animal Antimicrobial Peptides surged due to the Increased focus of the manufacturers and major market players.
• The Italy Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 10.4% during the forecast period, with a market size of USD 5.85 million in 2024.
• The Russia Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 10.0% during the forecast period, with a market size of USD 10.55 million in 2024.
• The Spain Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 10.1% during the forecast period with a market size of USD 5.58 million in 2024
• The Luxembourg Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.1% during the forecast period, with a market size of USD 2.11 million in 2024.
• The Portugal Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 10.8% during the forecast period, with a market size of USD 1.43 million in 2024.
• The Greece Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 0.82 million in 2024.
• The Rest of Europe's Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 9.7% during the forecast period, with a market size of USD 10.55 million in 2024.

Asia Pacific Animal Antimicrobial Peptides

According to Cognitive Market Research, the global Animal Antimicrobial Peptide market size was estimated at USD 226.9 Million, out of which Asia Pacific held the market share of around 23% of the global revenue with a market size of USD 52.19 million in 2024 and will grow at a compound annual growth rate (CAGR) of 14.5% from 2024 to 2031.

• According to Cognitive Market Research, the China Animal Antimicrobial Peptide market size was valued at USD 23.48 million in 2024 and is projected to grow at a CAGR of 14.0% during the forecast period. Animal Antimicrobial Peptides surged in China due to the Increased focus of the manufacturers and major market players.
• The Japan Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 7.20 million in 2024.
• The India Animal Antimicrobial Peptide market had a market share of USD 6.26 million in 2024 and is projected to grow at a CAGR of 16.3% during the forecast period. India's rising awareness among the populations .
• The South Korean Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 13.6% during the forecast period, with a market size of USD 5.22 million in 2024.
• The Australian Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 14.2% during the forecast period, with a market size of USD 2.71 million in 2024.
• The South East Asia Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 15.5% during the forecast period, with a market size of USD 3.60 million in 2024.
• The Rest of Asia Pacific Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 14.3% during the forecast period, with a market size of USD 3.71 million in 2024.

South America Animal Antimicrobial Peptides

According to Cognitive Market Research, the global Animal Antimicrobial Peptide market size was estimated at USD 226.9 Million, out of which Latin America held the market share of around 5% of the global revenue with a market size of USD 11.35 million in 2024 and will grow at a compound annual growth rate (CAGR) of 11.9% from 2024 to 2031.

• According to Cognitive Market Research, the Brazil Animal Antimicrobial Peptide market size was valued at USD 4.86 million in 2024 and is projected to grow at a CAGR of 12.5% during the forecast period. Animal Antimicrobial Peptides flourished in Brazil due to increasing demand for packaged food and beverages.
• Argentina's Animal Antimicrobial Peptide market had a market share of USD 1.91 million in 2024 and is projected to grow at a CAGR of 12.8% during the forecast period. Argentina's rising personal disposable income .
• Colombia Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 1.01 million in 2024.
• Peru Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 12.1% during the forecast period, with a market size of USD 0.93 million in 2024.
• Chile Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 12.2% during the forecast period, with a market size of USD 0.82 million in 2024.
• The Rest of Latin America's Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.0% during the forecast period, with a market size of USD 1.83 million in 2024.

Middle East Animal Antimicrobial Peptides

According to Cognitive Market Research, the global Animal Antimicrobial Peptide market size was estimated at USD 226.9 Million, out of which the Middle East and Africa held the major market share of around 2% of the global revenue with a market size of USD 4.54 million in 2024 and will grow at a compound annual growth rate (CAGR) of 12.2% from 2024 to 2031..

• The GCC Countries Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 13.0% during the forecast period, with a market size of USD 1.94 million in 2024. Animal Antimicrobial Peptide sales flourish due to the presence of major market players.
• The Egypt Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 12.5% during the forecast period, with a market size of USD 0.48 million in 2024.
• The South Africa Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 13.2% during the forecast period, with a market size of USD 0.72 million in 2024. Animal Antimicrobial Peptide sales flourished in South Africa due to increasing demand and regulatory support.
• The Turkey Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.7% during the forecast period, with a market size of USD 0.39 million in 2024.
• The Nigeria Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.3% during the forecast period, with a market size of USD 0.48 million in 2024.
• The Rest of the MEA Animal Antimicrobial Peptide market is projected to witness growth at a CAGR of 11.2% during the forecast period, with a market size of USD 0.54 million in 2024.

Animal Antimicrobial Peptides Market Analysis

How are Segments Performing in the Global Animal Antimicrobial Peptide Market?

Animal Antimicrobial Peptide Market Product Segment Analysis

According to Cognitive Market Research, Plant antimicrobial peptides (AMPs) dominate the animal antimicrobial peptide market due to their broad-spectrum efficacy, low toxicity, and sustainable sourcing. They effectively combat various pathogens, making them valuable alternatives to traditional antibiotics. With increasing concerns over antibiotic resistance, the demand for natural antimicrobial agents has surged. Plant AMPs are versatile in applications across veterinary medicine and animal feed, driving market growth as they offer eco-friendly solutions for enhancing animal health and productivity. Their innovative potential fuels ongoing research and development.

Plant insect antimicrobial peptides (AMPs) dominate the animal antimicrobial peptide market due to their broad-spectrum activity against various pathogens, including bacteria, fungi, and viruses. These peptides exhibit high stability, low toxicity, and strong bioactivity, making them ideal alternatives to traditional antibiotics. Their natural origin and effectiveness in enhancing animal health and growth drive demand in the livestock and aquaculture sectors. Additionally, increasing concerns about antibiotic resistance further boost interest in plant-insect AMPs as sustainable solutions for disease management.

The above Chart is for representative purposes and does not depict actual sale statistics. Access/Request the quantitative data to understand the trends and dominating segment of Animal Antimicrobial Peptides Industry. Request a Free Sample PDF!

Animal Antimicrobial Peptide Market Ailments Segment Analysis

According to Cognitive Market Research, Pneumonia significantly drives the animal antimicrobial peptide market due to the increasing incidence of respiratory infections in livestock and pets. The rising awareness of antibiotic resistance pushes veterinarians and animal owners toward alternative treatments, leading to a higher demand for antimicrobial peptides. These peptides are effective against bacterial infections, including pneumonia, and are viewed as safer options compared to traditional antibiotics. Consequently, the focus on improving animal health and productivity enhances the market's growth for these innovative solutions.

In the Animal Antimicrobial Peptide Market, HIV is driving growth in the Animal Antimicrobial Peptide (AMP) market due to the increasing need for effective disease management in livestock and aquaculture. As antimicrobial resistance rises, there is a heightened demand for alternative therapies like AMPs. Research into HIV's ability to influence immune responses also fosters innovation in AMP formulations. Additionally, regulatory support and advancements in peptide synthesis technology contribute to the market's expansion, positioning AMPs as crucial solutions for enhancing animal health and productivity.

The above Graph is for representation purposes only. This chart does not depict actual Market share.

Animal Antimicrobial Peptides Route Of Administration Segment Analysis

Animal Antimicrobial Peptide Market Route of Administration Segment Analysis

According to Cognitive Market Research, Topical applications dominate the Animal Antimicrobial Peptide (AMP) market due to their direct application on affected areas, providing immediate therapeutic effects. They are favored for preventing infections in wounds, skin diseases, and surgical sites in animals. The rise in antibiotic resistance further enhances the appeal of AMPs, as they offer an effective alternative to traditional antibiotics. Additionally, their ability to promote healing and reduce inflammation drives adoption among veterinarians, contributing to their significant market share.

In the Animal Antimicrobial Peptide market, the rapidly growing sector is Intravenous (IV) administration dominates the fastest-growing Animal Antimicrobial Peptide (AMP) market due to its rapid absorption and immediate therapeutic effects. This method is crucial for treating severe infections in animals, ensuring high bioavailability of AMPs. Additionally, the increasing prevalence of antibiotic resistance in veterinary medicine drives the demand for alternative therapies like AMPs, particularly through IV delivery. The effectiveness of this administration route in critical care settings further enhances its market dominance.

• Topical
• Subcutaneous
• Intravenous

Animal Antimicrobial Peptides End-user Segment Analysis

Animal Antimicrobial Peptide Market End-user Segment Analysis

According to Cognitive Market Research, the Pharma and Healthcare sectors dominate the Animal Antimicrobial Peptide Market due to the rising demand for innovative alternatives to traditional antibiotics in livestock and aquaculture. This shift is driven by increasing antibiotic resistance and stringent regulations on antibiotic use in animals. Furthermore, pharmaceutical companies are investing in research and development to enhance the efficacy and safety of antimicrobial peptides. Collaborations between biotech firms and healthcare providers further bolster market growth, addressing the need for sustainable animal health solutions.

Biological engineering dominates the animal antimicrobial peptide market by leveraging advanced biotechnological methods to optimize peptide production and enhance their efficacy against pathogens. Through genetic modifications and synthetic biology, researchers can create peptides with improved stability, potency, and specificity. This innovation leads to the development of novel antimicrobial agents that address antibiotic resistance in livestock, ensuring animal health and productivity. Additionally, regulatory support and rising demand for natural alternatives in veterinary medicine further propel growth in this sector.

• Pharma and Healthcare
• Agriculture Industry
• Biological Engineering

Animal Antimicrobial Peptides Distribution Channel Segment Analysis

Animal Antimicrobial Peptide Market Distribution Channel Segment Analysis

According to Cognitive Market Research, Hospitals dominate the largest animal antimicrobial peptide market due to their extensive use of these peptides in veterinary medicine and livestock management. They prioritize animal health by preventing infections, enhancing growth, and reducing antibiotic resistance. Advanced research facilities in hospitals contribute to the development of innovative antimicrobial peptide therapies. Additionally, hospitals' regulatory compliance and quality standards ensure the safe and effective use of these peptides, driving their adoption in animal husbandry and veterinary practices.

Pharmacies dominate the fastest-growing Animal Antimicrobial Peptide market through increased access to veterinary products and personalized medication. They provide a vital link between manufacturers and pet owners, offering a wide range of antimicrobial peptides that address various health issues in animals. With the rise in awareness of antibiotic resistance, pharmacies promote alternative treatments, enhancing their role in animal health. Additionally, their convenience, expert advice, and ability to cater to specific animal needs drive significant demand for these products.

• Hospital
• Research Institutes
• Specialty Clinic
• Pharmacies

Author's Detail

Manoj Phagare

Senior Research Analyst at Cognitive Market Research

LinkedIn

Profile

• Worked on several market, industry & business research projects, on various models such as Syndicated, Custom, Subscriptions and Consults
• Proficient in secondary research and familiar with all paid research databases
• Proficient in primary research and handling client queries through mails and calls
• Expertise in statistical techniques used in data forecasting, possess strong grip on all aspects of market engineering & data analysis
• Expertise in checking feasibility of projects based on Request for Proposal (RFPs) of clients
• Acquainted with entire process of report writing- Title Analysis, TOC Building, Search Engine Optimization, TOC Freezing, Writing Reports, Market Engineering, Scheduling Primaries, Directory of Key Industry Participants (DKIP), Drafting “Press Articles/Summary/Report Description/Analyst Briefing” used for making marketing collaterals 
• Gained team-work skills in coordinating with the sales teams for business development and meeting needs of a variety of clients hand-in-hand with promoting sales.

Author's Conclusion